• Mashup Score: 6
    Registration - 10 hour(s) ago

    Registration

    Tweet Tweets with this article
    • Early-bird pricing for #NYValves2025 ends TONIGHT at 11:59 PM EDT! Register now to secure your spot in the most anticipated structural heart disease meeting of the year: https://t.co/C5FVC4ey4L #interventionalcardiology @crfheart https://t.co/Hy21qKipY2

  • Mashup Score: 0

    Mamas Mamas talks to Tesfaye Telila about the landscape of acute coronary care in Ethiopa, where just a few dozen cardiologists contend with a population of 120 million people.

    Tweet Tweets with this article
    • Acute Coronary Care in Ethiopia https://t.co/6KMybeU1mK https://t.co/1b9ttnzjwV

  • Mashup Score: 11

    The combination will be available in several doses and is also approved as a first-line option for patients with hypertension.

    Tweet Tweets with this article
    • The first triple therapy polypill to treat patients with hypertension has been approved by the @US_FDA. The pill, Widaplik, contains the ARB telmisartan, calcium-channel blocker amlodipine, and diuretic indapamide. Read the latest here: https://t.co/NFC5Oy0gVl https://t.co/JhvmNkmO8D

  • Mashup Score: 0

    Martin B. Leon, MD Columbia University New York, NY Tsuyoshi Kaneko, MD Washington University St. Louis, MO Brian Lindman, MD Vanderbilt University Nashville, TN Jeffrey Popma, MD Harvard Medical School Cambridge, MA Forgot Your Password? Enter the email you used to register to reset your password.

    Tweet Tweets with this article
    • DurAVR® THV is a novel biomimetic valve that aims to restore native flow in patients with aortic stenosis. In our latest webcast, a panel of experts provides insight on this new treatment option: https://t.co/novsZ9IwSa https://t.co/BAd1zu0XBB

  • Mashup Score: 6
    Registration - 1 day(s) ago

    Registration

    Tweet Tweets with this article
    • Early-bird pricing for #NYValves2025 ends TONIGHT at 11:59 PM EDT! Register now to secure your spot in the most anticipated structural heart disease meeting of the year: https://t.co/C5FVC4ey4L #interventionalcardiology @crfheart https://t.co/Hy21qKipY2